News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Does Zogenix, Inc. (ZGNX) Need a Painkiller? A Drugmaker Struggles With Controversy



8/8/2014 6:31:37 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Judging by some recent events, the Zogenix executive team may want to reach for a painkiller. Over the past week, the drug maker suffered a pair of setbacks. First, Express Scripts , the nation’s largest pharmacy benefits manager, removed its Zohydro ER prescription painkiller from its national formulary, or list of medicines for which reimbursement is provided. Then, the chief commercial officer, Scott Shively, resigned to take another job. And now, the sales and marketing team is undergoing an internal review.

Hey, check out all the research scientist jobs. Post your resume today!



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES